Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study for Predictive Marker for Decitabine Treament in MDS Patients

NCT02045654 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02045654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02045654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study for Predictive Marker for Decitabine Treament in MDS Patients
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
March 31, 2015
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome